Advertisement
Physician's Briefing Weekly Coronavirus Roundup

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

Measles Cases Reach Highest Number in 23 Years

0

After steady decline in 2010 to 2016, measles cases increased in all WHO regions from 2017 to 2019; deaths increased 50 percent

ACR: Incidence of COVID-19 Low in Patients With Rheumatic Disease

0

73 percent of those with SARS-CoV-2 infection not hospitalized; 11 percent of those hospitalized required ICU admission

Major Neurological Disorders on the Rise in the United States

CDC: 26.4 Percent of U.S. Adults With Diabetes Meet ABCS Goals

0

About one in four meet combined goals of management of blood glucose, BP, non-HDL-C, avoiding smoking

ACR: Corticosteroid Injections Do Not Speed Progression of Knee OA

0

Rates of radiographic progression similar for corticosteroid injections, hyaluronic acid injections in multivariable analysis

Statins Tied to Lower In-Hospital COVID-19 Mortality Risk

0

For adults hospitalized in Spain with COVID-19, treatment with statins associated with lower COVID-19-related mortality

Targeted Efforts Do Not Alter Outcomes in Healthy Elderly

0

For seniors, vitamin D, omega-3 supplement, strength training, alone or in combination, do not improve clinical outcomes

Outcomes Mixed After Heart Transplant Policy Change in the U.S.

AHA: Mavacamten May Treat Hypertrophic Cardiomyopathy

0

Improvements in cardiac structure, function seen at 30 weeks of treatment with mavacamten versus placebo

HealthDay Reports: Preoperative COVID-19 Incidence

Risks of Opioids Should Be Recognized for Children After Surgery

0

Opioid prescribing guidelines for children developed; authors underscore importance of nonopioid analgesic options, providing education to patients and their families

COVID-19-Linked Ischemic Strokes More Severe

NHLBI Trial Concludes No Benefit for Hydroxychloroquine in COVID-19

0

No clinical benefit found for hydroxychloroquine versus placebo in hospitalized adults with COVID-19